A Trial to Evaluate the Superior Mesenteric Vein (14V) Lymphadenectomy for Distal Advanced Gastric Cancer

Summary

This trial is going to evaluate the advantage of D2 radical gastrectomy plus 14v lymph node dissection in 3-year survival rates of advanced gastric cancers.

Conditions

• Gastric Cancer

Interventions

PROCEDURE

Dissection of the Superior Mesenteric Vein Lymph Node

14v lymph node dissection

Sponsors & Collaborators

• The First Affiliated Hospital with Nanjing Medical University

  collaborator OTHER

• Shanxi Province Cancer Hospital

  collaborator OTHER

• Peking University Cancer Hospital & Institute

  collaborator OTHER

• Qingdao University

  collaborator OTHER

• Fudan University

  collaborator OTHER

• Sun Yat-sen University

  collaborator OTHER

• Harbin Medical University

  collaborator OTHER

• Cancer Institute and Hospital, Chinese Academy of Medical Sciences

  collaborator OTHER

• The First Affiliated Hospital of Dalian Medical University

  collaborator OTHER

• Qinghai University

  collaborator OTHER

• Second Hospital of Jilin University

  collaborator OTHER

• The First Affiliated Hospital of Zhengzhou University

  collaborator OTHER

• Wulumuqi General Hospital of Lanzhou Military Command

  collaborator OTHER

• Shandong Provincial Hospital

  collaborator OTHER_GOV

• Nanjing PLA General Hospital

  collaborator OTHER

• Tianjin Medical University Cancer Institute and Hospital

  lead OTHER

Principal Investigators

• Han Liang, Master · Tianjin Medical University Cancer Hospital

Eligibility

Min Age

18 Years

Max Age

70 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2014-07-31

Primary Completion

2016-11-30

Completion

2016-12-31

Countries

• China

Study Locations